C. Graeb

发表

[Surgical treatment of chronic pancreatitis: indications, timing, methods].

O. Vorontsov, I. Natroshvili, I. Mikhin, 2022, Khirurgiia.

PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATION

E. Geissler, M. Guba, K. Jauch, 2004, Transplantation.

Arterial blood flow predicts graft survival in liver transplant patients

K. Jauch, C. Graeb, M. Rentsch, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Effect of graft steatosis on liver function and organ survival after liver transplantation.

K. Jauch, C. Graeb, M. Rentsch, 2008, American journal of surgery.

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

V. Mazzaferro, P. Lamby, I. Bilbao, 2010, BMC Cancer.

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

G. Schmid, E. Geissler, M. Guba, 2005, Blood.

Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.

B. Banas, C. Böger, B. Krämer, 2007, Transplantation proceedings.

Atrial Resection for Lung Cancer: Morbidity, Mortality, and Long-Term Follow-up

M. Lindner, A. Kuehnl, R. Hatz, 2010, World Journal of Surgery.

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

V. Mazzaferro, P. Lamby, I. Bilbao, 2015, Transplantation.

[Acute abdomen: clinical background and demands on imaging].

M. Reiser, A. Graser, K. Jauch, 2010, Der Radiologe.

Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation

A. Gerbes, U. Löhrs, U. Beuers, 2007, Clinical transplantation.

Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.

B. Krämer, M. Fischereder, K. Jauch, 2006, Transplantation proceedings.

presence of VEGF Rapamycin induces tumor-specific thrombosis via tissue factor in the

G. Schmid, E. Geissler, K. Jauch, 2013 .

Contrast-enhanced ultrasound in liver transplant: first results and potential for complications in the postoperative period.

M. Reiser, D. Clevert, K. Jauch, 2009, Clinical hemorheology and microcirculation.

Surgery in immunocompromised patients

K. Jauch, C. Graeb, 2007, The British journal of surgery.

Interventionen bei der Pankreatitis

C. Graeb, B. Radeleff, K. Dubasz, 2021, Der Radiologe.

THE ANTINEOPLASTIC DRUG PACLITAXEL HAS IMMUNOSUPPRESSIVE PROPERTIES THAT CAN EFFECTIVELY PROMOTE ALLOGRAFT SURVIVAL IN A RAT HEART TRANSPLANT MODEL1

E. Geissler, K. Jauch, C. Graeb, 2002, Transplantation.

The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.

A. Crispin, M. Guba, K. Jauch, 2007, Kidney international.

Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients.

E. Geissler, M. Guba, K. Jauch, 2000, Human gene therapy.

Late reuse of liver allografts from brain‐dead graft recipients: The Munich experience and a review of the literature

K. Jauch, C. Graeb, M. Rentsch, 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

SELECTIVE INTESTINAL DECONTAMINATION IN PATIENTS WITH ACUTE DIVERTICULITIS COMPLICATED BY COVERED PERFORATION AS A WAY TO REDUCE THE NUMBER OF POSTOPERATIVE COMPLICATIONS

O. Vorontsov, I. Mikhin, C. Graeb, 2020 .

Cyclosporine: 20 years of experience at the University of Munich.

M. Guba, K. Jauch, C. Graeb, 2004, Transplantation proceedings.

Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.

C. Heeschen, G. Schmid, M. Guba, 2007, Kidney international.

FTY720 INHIBITS TUMOR GROWTH AND ANGIOGENESIS

G. Schmid, M. Guba, K. Jauch, 2004, Transplantation proceedings.

RAPAMYCIN PROTECTS ALLOGRAFTS FROM REJECTION WHILE SIMULTANEOUSLY ATTACKING TUMORS IN IMMUNOSUPPRESSED MICE

G. Koehl, E. Geissler, M. Guba, 2004, Transplantation.

Rapamycin verhindert Abstossung und Tumorwachstum in einem Tumor-Transplantations-Modell in der Maus Rapamycin inhibits graft rejection and tumor growth in a tumor transplant model in mice

M. Guba, C. Graeb, G. KohP, 2004 .

Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy.

C. Heeschen, G. Schmid, M. Guba, 2005, Kidney international.

Surgery for Metastasis to the Pancreas: Is it Safe and Effective?

K. Jauch, C. Conrad, C. Graeb, 2013, Journal of surgical oncology.

Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling

M. Guba, K. Jauch, C. Graeb, 2008, Oncogene.

Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms.

X. Hong, J. Fechner, S. Knechtle, 1997, Journal of immunology.

Long-term results after surgical treatment of nonparasitic hepatic cysts.

K. Jauch, C. Graeb, C. Bruns, 2010, American journal of surgery.

Acute pneumatosis cystoides intestinalis following allogeneic transplantation – the surgeon's dilemma

E. Holler, M. Strotzer, K. Jauch, 2002, Bone Marrow Transplantation.

Quality of Life in Peritoneal Carcinomatosis: A Prospective Study in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

J. Werner, C. Graeb, M. Angele, 2014, Digestive Surgery.

[Usage of marginal organs for liver transplantation: a way around the critical organ shortage?].

K. Jauch, C. Graeb, M. Angele, 2009, Zentralblatt fur Chirurgie.

Acute liver failure, rupture and hemorrhagic shock as primary manifestation of advanced metastatic disease.

K. Jauch, C. Graeb, C. Zech, 2012, Anticancer research.

HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis

V. Mazzaferro, P. Lamby, I. Bilbao, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

mTOR Inhibition and its Effect on Cancer in Transplantation

M. Guba, C. Graeb, M. Rentsch, 2005, Transplantation.

Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti‐donor humoral and cellular immune response: implications for transplant patients with cancer

E. Geissler, K. Jauch, C. Graeb, 2003 .

Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti-donor humoral and cellular immune response: implications for transplant patients with cancer

E. Geissler, K. Jauch, C. Graeb, 2003, Transplant international : official journal of the European Society for Organ Transplantation.

β-Catenin mutations in 2 nested stromal epithelial tumors of the liver--a neoplasia with defective mesenchymal-epithelial transition.

R. Kappler, C. Graeb, A. Jung, 2012, Human pathology.

The dark side of the moon: Impact of moon phases on long-term survival, mortality and morbidity of surgery for lung cancer

A. Kuehnl, K. Jauch, C. Graeb, 2009, European journal of medical research.

THEDARKSIDE OF THEMOON:IMPACT OFMOONPHASES ON LONG-TERMSURVIVAL,MORTALITY ANDMORBIDITY OFSURGERY FOR LUNGCANCER

A. Kuehnl, R. Hatz, K. Jauch, 2009 .

Individual approaches to complex stage-by-stage treatment of complications of chronic pancreatitis

T. Mueller, O. Vorontsov, I. Mikhin, 2021, Endoskopicheskaya khirurgiya.

Esophageal Leiomyomatosis Combined With Intrathoracic Stomach and Gastric Volvulus

K. Jauch, C. Graeb, R. Lang, 2009, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

Split tolerance induced by immunotoxin in a rhesus kidney allograft model.

J. Fechner, S. Knechtle, D. Neville, 1997, Transplantation.

protocolA prospective randomised , open-labeled , trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

V. Mazzaferro, P. Lamby, I. Bilbao, 2010 .

[Diagnosis and multimodal therapy for hepatocellular carcinoma].

R. Lamerz, K. Herrmann, F. Kolligs, 2010, Zeitschrift fur Gastroenterologie.

Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.

S. Knechtle, E. Geissler, C. Graeb, 1998, Human immunology.

Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: Hepatocyte‐expressed membrane‐bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats

E. Geissler, K. Jauch, C. Graeb, 2000, Hepatology.

Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients.

E. Geissler, K. Jauch, C. Graeb, 2002, Human immunology.

The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1‐phosphate receptor 1

C. Heeschen, G. Schmid, M. Guba, 2007, Journal of cellular biochemistry.

Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responses.

E. Geissler, C. Graeb, W. Korzun, 1997, Transplantation.

Early experience with the ET Senior Program "Old For Old"; better to be number one?

B. Krämer, M. Fischereder, K. Jauch, 2002, Transplant International.

Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients

M. Guba, K. Jauch, C. Graeb, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

An adenoviral gene transfer system to express high levels of soluble allogeneic MHC class I molecules in vitro and in vivo.

E. Geissler, K. Jauch, C. Graeb, 2002, Transplantation Proceedings.

Expression of high levels of soluble allogeneic major histocompatability complex class I antigen by adenoviral gene transfer strongly inhibits allospecific cytotoxic T lymphocytes in vivo.

E. Geissler, K. Jauch, C. Graeb, 2002, Transplantation proceedings.

KAPITEL 50 – Akutes Abdomen

K. Jauch, C. Graeb, P. Vogel, 2009 .

Liver Resection or Combined Chemoembolization and Radiofrequency Ablation Improve Survival in Patients with Hepatocellular Carcinoma

M. Reiser, T. Helmberger, W. Caselmann, 2007, Digestion.

The University of Munich lung cancer group database: design, profile of cohort and outcome analysis.

K. Jauch, C. Graeb, M. Schmidt, 2007, European journal of medical research.

B-Flow Sonography for Detecting Portal Venous Stenosis After Liver Transplantation

M. Reiser, D. Clevert, H. Michaely, 2006 .

Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients.

E. Geissler, K. Jauch, C. Graeb, 2002, Human immunology.

Diagnose und multimodale Therapie des hepato-zellulären Karzinoms Diagnosis and Multimodal Therapy for Hepatocellular Carcinoma

C. Graeb, C. Zech, T. Jakobs, 2022 .

Akutes Abdomen

M. Reiser, A. Graser, K. Jauch, 2009, Der Radiologe.

Interferon-Induced Hepatic Failure in a Patient With Hepatitis C

C. Graeb, M. Anthuber, G. Lock, 1999, American Journal of Gastroenterology.

Open Access Study Protocol a Prospective Randomised, Open-labeled, Trial Comparing Sirolimus-containing versus Mtor-inhibitor-free Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

I. Bilbao, W. Bechstein, P. Neuhaus, 2022 .

Intrapancreatic ectopic spleen: difficulties in differential diagnosis

O. Vorontsov, I. Mikhin, C. Graeb, 2023, Endoskopicheskaya khirurgiya.

Transplantationsmedizin und Immunsuppression

C. Graeb, M. Guba, 2013 .

Successful heparin-perfusion therapy for complete thrombosis of the intra- and extrahepatic portal and mesenteric vein. A case report and literature review

C. Graeb, B. Radeleff, M. Mishra, 2022, Radiology case reports.

LAPAROSCOPIC AND ROBOTIC-ASSISTED SURGERYFOR COMPLICATED DIVERTICU

O. Vorontsov, I. Mikhin, C. Graeb, 2020, Archiv Euromedica.

Retrospective assessment of the possibilities of minimally invasive interventions in cases of complicated chronic pancreatitis

O. Vorontsov, I. Mikhin, C. Graeb, 2022, Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery.

Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer.

E. Geissler, K. Jauch, C. Graeb, 2002, Transplantation Proceedings.

Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant model

E. Geissler, C. Graeb, M. Scherer, 2000 .

Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high‐responder heart transplant model

E. Geissler, C. Graeb, M. Scherer, 2000, Transplant international : official journal of the European Society for Organ Transplantation.

Surgery in immunocompromised patients

K. Jauch, C. Graeb, 2007, The British journal of surgery.

Soluble donor MHC class I gene therapy prevents accelerated heart allograft rejection in actively sensitized rat recipients.

E. Geissler, K. Jauch, C. Graeb, 2001, Transplantation proceedings.

Effect of portal vein injection of allo-MHC-transfected hepatocytes on immunity prior to organ transplantation.

E. Geissler, C. Graeb, 1997, Transplantation proceedings.